SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A POS -
SEC Accession No. 0001753926-21-000509
Filing Date
2021-09-30
Accepted
2021-09-30 16:23:12
Documents
19

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A POS  
1 primary_doc.xml 1-A POS 10957
2 PART II AND III g082366_partiiandiii.htm PART II AND III 1173356
3 g082366_ex3.htm EX1A-6 MAT CTRCT 99100
4 g082366_ex3-1.htm EX1A-6 MAT CTRCT 117886
5 g082366_ex4.htm EX1A-4 SUBS AGMT 74842
6 g082366_ex6.htm ADD EXHB 962359
7 g082366_ex7.htm EX1A-12 OPN CNSL 15466
8 g082366_ex8.htm EX1A-14 CNSNT SV 2345
9 GRAPHIC img001_v1.jpg GRAPHIC 3092
10 GRAPHIC img002_v1.jpg GRAPHIC 2812
11 GRAPHIC img003_v1.jpg GRAPHIC 4364
12 GRAPHIC img011_v1.jpg GRAPHIC 3098
13 GRAPHIC img004_v1.jpg GRAPHIC 128438
14 GRAPHIC img005_v1.jpg GRAPHIC 8902
15 GRAPHIC img010_v1.jpg GRAPHIC 5413
16 GRAPHIC img006_v1.jpg GRAPHIC 4856
17 GRAPHIC img007_v1.jpg GRAPHIC 4239
18 GRAPHIC img008_v1.jpg GRAPHIC 4752
19 GRAPHIC img009_v1.jpg GRAPHIC 1612
  Complete submission text file 0001753926-21-000509.txt   2694730
Mailing Address 20 CORPORATE PARK SUITE 400 IRVINE CA 92606
Business Address 20 CORPORATE PARK SUITE 400 IRVINE CA 92606 925-202-6000
XEME Biopharma Holdings Inc. (Filer) CIK: 0001775196 (see all company filings)

IRS No.: 834309196 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 1-A POS | Act: 33 | File No.: 024-10996 | Film No.: 211295328
SIC: 2834 Pharmaceutical Preparations